About this episode
Episode 39
With the confirmation that malaria parasites in Rwanda have developed resistance to artemisinin — a first-line drug used to treat malaria, which kills around 400,000 people a year worldwide — public health teams in Africa are asking what this could mean for the battle against malaria. Elsewhere on the continent, malaria vaccine trials have reported success.
This week on Africa Science Focus, reporter Charles Pensulo speaks to Karen Barnes from the University of Cape Town, who leads the Worldwide Antimalarial Resistance Network’s Southern Africa Regional Centre, and malaria specialist Elizabeth Juma, a medical officer with the World Health Organization.
And, in this week’s Q&A segment, Wakin Octavia from Henry Henderson Institute in Malawi has a question about chemistry.
Is there something you want to know about life, health or science in Africa? Send us your questions from anywhere in the world and we’ll find an expert to answer them — text or voice message via WhatsApp to +254799042513.
Africa Science Focus, with Selly Amutabi.
Do you have any comments, questions or feedback about our podcast episodes? Let us know at [email protected]
Get every episode summarized
Each time Africa Science Focus publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Africa Science Focus
Climate-smart actions to reduce crop loss in Africa
Africa Science Focus
How can better data curb Africa’s crop loss crisis?
Africa Science Focus
Why plant health matters for One Health systems
Africa Science Focus
Advancing gender equality in research
Africa Science Focus